These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


501 related items for PubMed ID: 30562098

  • 21. Altered systemic ketone body metabolism in advanced heart failure.
    Janardhan A, Chen J, Crawford PA.
    Tex Heart Inst J; 2011; 38(5):533-8. PubMed ID: 22163128
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Free fatty acids and heart failure in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Nomura SO, Karger AB, Weir NL, Lima JAC, Thanassoulis G, Tsai MY.
    J Clin Lipidol; 2021; 15(4):608-617. PubMed ID: 34244123
    [Abstract] [Full Text] [Related]

  • 25. Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics.
    Santos-Gallego CG, Requena-Ibanez JA, San Antonio R, Ishikawa K, Watanabe S, Picatoste B, Flores E, Garcia-Ropero A, Sanz J, Hajjar RJ, Fuster V, Badimon JJ.
    J Am Coll Cardiol; 2019 Apr 23; 73(15):1931-1944. PubMed ID: 30999996
    [Abstract] [Full Text] [Related]

  • 26. Effect of insulin and acute diabetes on plasma FFA and ketone bodies in the fasting rat.
    Bieberdorf FA, Chernick SS, Scow RO.
    J Clin Invest; 1970 Sep 23; 49(9):1685-93. PubMed ID: 5452413
    [Abstract] [Full Text] [Related]

  • 27. Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study.
    Gormsen LC, Svart M, Thomsen HH, Søndergaard E, Vendelbo MH, Christensen N, Tolbod LP, Harms HJ, Nielsen R, Wiggers H, Jessen N, Hansen J, Bøtker HE, Møller N.
    J Am Heart Assoc; 2017 Feb 27; 6(3):. PubMed ID: 28242634
    [Abstract] [Full Text] [Related]

  • 28. Effects of short-term manipulation of serum FFA concentrations on left ventricular energy metabolism and function in patients with heart failure: no association with circulating bio-markers of inflammation.
    Salerno A, Fragasso G, Esposito A, Canu T, Lattuada G, Manzoni G, Del Maschio A, Margonato A, De Cobelli F, Perseghin G.
    Acta Diabetol; 2015 Aug 27; 52(4):753-61. PubMed ID: 25559351
    [Abstract] [Full Text] [Related]

  • 29. Arrhythmogenic gene remodelling in elderly patients with type 2 diabetes with aortic stenosis and normal left ventricular ejection fraction.
    Ashrafi R, Modi P, Oo AY, Pullan DM, Jian K, Zhang H, Gerges JY, Hart G, Boyett MR, Davis GK, Wilding JPH.
    Exp Physiol; 2017 Nov 01; 102(11):1424-1434. PubMed ID: 28804970
    [Abstract] [Full Text] [Related]

  • 30. Complex Energy Metabolic Changes in Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction.
    De Jong KA, Lopaschuk GD.
    Can J Cardiol; 2017 Jul 01; 33(7):860-871. PubMed ID: 28579160
    [Abstract] [Full Text] [Related]

  • 31. Low-flow severe aortic stenosis with preserved ejection fraction, N-terminal pro-brain natriuretic peptide (NT-proBNP) and cardiovascular remodeling.
    Mizia-Stec K, Adamczyk T, Mizia M, Haberka M, Gasior Z, Trusz-Gluza M, Tendera M.
    J Heart Valve Dis; 2011 May 01; 20(3):301-10. PubMed ID: 21714421
    [Abstract] [Full Text] [Related]

  • 32. Mitochondrial Morphology, Dynamics, and Function in Human Pressure Overload or Ischemic Heart Disease With Preserved or Reduced Ejection Fraction.
    Chaanine AH, Joyce LD, Stulak JM, Maltais S, Joyce DL, Dearani JA, Klaus K, Nair KS, Hajjar RJ, Redfield MM.
    Circ Heart Fail; 2019 Feb 01; 12(2):e005131. PubMed ID: 30744415
    [Abstract] [Full Text] [Related]

  • 33. Prognostic significance of myocardial energy expenditure and myocardial efficiency in patients with heart failure with reduced ejection fraction.
    Cetin MS, Ozcan Cetin EH, Canpolat U, Sasmaz H, Temizhan A, Aydogdu S.
    Int J Cardiovasc Imaging; 2018 Feb 01; 34(2):211-222. PubMed ID: 28808841
    [Abstract] [Full Text] [Related]

  • 34. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.
    Doenst T, Pytel G, Schrepper A, Amorim P, Färber G, Shingu Y, Mohr FW, Schwarzer M.
    Cardiovasc Res; 2010 Jun 01; 86(3):461-70. PubMed ID: 20035032
    [Abstract] [Full Text] [Related]

  • 35. Association of beta-hydroxybutyrate with development of heart failure: Sex differences in a Dutch population cohort.
    Flores-Guerrero JL, Westenbrink BD, Connelly MA, Otvos JD, Groothof D, Shalaurova I, Garcia E, Navis G, de Boer RA, Bakker SJL, Dullaart RPF.
    Eur J Clin Invest; 2021 May 01; 51(5):e13468. PubMed ID: 33616911
    [Abstract] [Full Text] [Related]

  • 36. Comparison of Prognostic Usefulness of Serum Insulin-Like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction.
    Hage C, Bjerre M, Frystyk J, Gu HF, Brismar K, Donal E, Daubert JC, Linde C, Lund LH.
    Am J Cardiol; 2018 Jun 15; 121(12):1558-1566. PubMed ID: 29622288
    [Abstract] [Full Text] [Related]

  • 37. Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients.
    Nielsen R, Møller N, Gormsen LC, Tolbod LP, Hansson NH, Sorensen J, Harms HJ, Frøkiær J, Eiskjaer H, Jespersen NR, Mellemkjaer S, Lassen TR, Pryds K, Bøtker HE, Wiggers H.
    Circulation; 2019 Apr 30; 139(18):2129-2141. PubMed ID: 30884964
    [Abstract] [Full Text] [Related]

  • 38. Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure.
    Bedi KC, Snyder NW, Brandimarto J, Aziz M, Mesaros C, Worth AJ, Wang LL, Javaheri A, Blair IA, Margulies KB, Rame JE.
    Circulation; 2016 Feb 23; 133(8):706-16. PubMed ID: 26819374
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Influence of ketone body infusion on plasma growth hormone and glucagon in man.
    Quabbe HJ, Trompke M, Luyckx AS.
    J Clin Endocrinol Metab; 1983 Sep 23; 57(3):613-8. PubMed ID: 6348066
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 26.